In the case of vaccines, phase one trials tell you if there's an immune response to the antigen being used. This is a good first approximation of effectiveness.

In the case of vaccines, phase one trials tell you if there's an immune response to the antigen being used. This is a good first approximation of effectiveness. The level of response could still be too low, but at least there's something happening.